Venlafaxine (VEN), a first-line antidepressant, and Zuojin Pill (ZJP), a common Chinese herbal medicine consisting of and , have a high likelihood of combination usage in patients with depression with gastrointestinal complications. ZJP exhibits inhibitory effects on recombinant human cytochrome P450 isoenzymes (rhP450s), especially on CYP2D6, whereas VEN undergoes extensive metabolism by CYP2D6. From this perspective, we investigated the influence of ZJP on the metabolism of VEN in vitro and in rats for the first time. In this study, ZJP significantly inhibited the metabolism of VEN in both rat liver microsomes (RLM) and human liver microsomes (HLM); meanwhile, it inhibited the -demethylation catalytic activity of RLM, HLM, rhCYP2D6*1/*1, and rhCYP2D6*10/*10, primarily through CYP2D6, with IC values of 129.9, 30.5, 15.4, and 2.3 μg/ml, respectively. Furthermore, the inhibitory effects of ZJP on hepatic metabolism and pharmacokinetics of VEN could also be observed in the pharmacokinetic study of rats. The area under drug concentration-time curve- of VEN and its major metabolite -desmethylvenlafaxine (ODV) increased by 39.6% and 22.8%, respectively. The hepatic exposure of ODV decreased by 57.2% 2 hours after administration ( = 0.014). In conclusion, ZJP displayed inhibitory effects on hepatic metabolism and pharmacokinetics of VEN in vitro and in rats mainly through inhibition of CYP2D6 activity. The human pharmacokinetic interaction between ZJP and VEN and its associated clinical significance needed to be seriously considered. SIGNIFICANCE STATEMENT: Zuojin Pill, a commonly used Chinese herbal medicine, demonstrates significant inhibitory effects on hepatic metabolism and pharmacokinetics of venlafaxine in vitro and in rats mainly through suppression of CYP2D6 activity. The human pharmacokinetic interaction between Zuojin Pill and venlafaxine and its associated clinical significance needs to be seriously considered.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1124/dmd.120.000048 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK/ERK/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation.
Drug Des Devel Ther
December 2024
School of Basic Medical Sciences, Shaanxi University of Chinese Medicine, Xianyang, People's Republic of China.
Background: Precancerous lesions of gastric cancer (PLGC) represent critical stages in gastric cancer progression, with a high risk of malignancy. Current treatments, such as Helicobacter pylori eradication, show limited efficacy in reversing precancerous molecular changes. Zuojin Pill (ZJP), a traditional Chinese medicine, has demonstrated potential for treating digestive disorders and may offer a promising approach for PLGC intervention.
View Article and Find Full Text PDFInvestigating the therapeutic effects and potential mechanisms of Zuojin Pill in the treatment of gastroesophageal reflux disease.
J Ethnopharmacol
January 2025
The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, China. Electronic address:
Article Synopsis
- Zuojin Pill (ZJP) is a traditional Chinese medicine known for its benefits in treating gastrointestinal issues, though its exact mechanisms for addressing gastroesophageal reflux disease (GERD) are still unclear.
- The study aimed to explore how ZJP affects GERD and uncover the molecular processes involved, using various experimental methods such as HPLC-Q-Exactive-MS for chemical analysis and multiple assays for biological effects.
- Findings showed that ZJP improved damaged esophageal tissues in GERD models by decreasing inflammation, maintaining mucosal barrier integrity, and influencing macrophage activity while inhibiting key signaling pathways involved in inflammation.
Zuojin Pill enhances gastrointestinal motility by modulating the pacemaker potentials in interstitial cells of Cajal through multiple signaling pathways.
Int J Med Sci
December 2024
Department of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
Article Synopsis
- Zuojin Pill (ZJP) is a traditional herbal remedy aimed at treating gastrointestinal disorders, and the study explores how it affects interstitial cells of Cajal (ICCs) and gut movement in mice.
- The research found that ZJP depolarizes ICCs, reducing their pacemaker activity and affecting calcium signaling, which is crucial for normal GI motility; this process is influenced by specific receptor interactions and various signaling pathways.
- Additionally, ZJP improved intestinal transit in mouse models of GI motility disorders and increased levels of key substances that promote gut movement, suggesting its potential as a therapeutic agent in digestive health.
Modified Zuojin pill alleviates gastric precancerous lesions by inhibiting glycolysis through the HIF-1α pathway.
Phytomedicine
January 2025
Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address:
Background: Gastric precancerous lesions (GPL) typically originates from chronic gastritis (CG), and the changes in glycolysis mediated by the HIF-1α pathway during the progression from CG to GPL are unclear. Modified Zuojin pill (SQQT) is a traditional Chinese herbal formula used for treating GPL. However, the underlying mechanism has not been fully elucidated.
View Article and Find Full Text PDFCharacterization of active alkaloids and metabolites in rats after oral administration of Zuojin Pill using UHPLC-Q-TOF-MS combined with bioinformatics and molecular docking analyses.
J Pharm Biomed Anal
October 2024
Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, The MOE Laboratory of Standardization of Chinese Medicines, Shanghai R&D Center for Standardization of Chinese Medicines, 1200 Cailun Road, 201203, China. Electronic address:
Article Synopsis
- Zuojin Pill (ZJP) is a traditional Chinese medicine primarily used for gastric disorders, composed of Rhizoma Coptidis and Euodiae Fructus in a 6:1 ratio.
- The study developed a method using UHPLC-Q-TOF-MS to analyze the in vivo metabolism and distribution of protoberberine alkaloids (PBAs) and indole alkaloids (IDAs) in rats, identifying 33 compounds, including 7 primary alkaloids and 26 metabolites.
- The findings revealed that these alkaloids and metabolites preferentially localized in the stomach and interacted strongly with key targets associated with gastritis, providing insights for future research into ZJP's therapeutic mechanisms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!